|
Volumn 184, Issue 1, 2001, Pages 112-115
|
Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: Implications for the mechanism underlying drug cure
a,c d a e f c b d |
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN G ANTIBODY;
IMMUNOGLOBULIN G1;
IMMUNOGLOBULIN G2;
IMMUNOGLOBULIN G3;
IMMUNOGLOBULIN G4;
STIBOGLUCONATE SODIUM;
ADOLESCENT;
ADULT;
ANTIBODY TITER;
ARTICLE;
CHILD;
CONTROLLED STUDY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
LEISHMANIA DONOVANI;
LEISHMANIASIS;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
SKIN TEST;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANTIBODIES, PROTOZOAN;
ANTIMONY SODIUM GLUCONATE;
ANTIPROTOZOAL AGENTS;
CHILD;
CHILD, PRESCHOOL;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
ETHIOPIA;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
LEISHMANIASIS, VISCERAL;
MALE;
MIDDLE AGED;
SKIN TESTS;
|
EID: 0035399852
PISSN: 00221899
EISSN: None
Source Type: Journal
DOI: 10.1086/320994 Document Type: Article |
Times cited : (41)
|
References (16)
|